Skip to main content
. 2021 Apr 2;15(4):1089–1098. doi: 10.1007/s12105-021-01318-4

Table 3.

Morphologic types and features by high risk HPV type

HPV16 Non HPV16 p value
All patients 212 (94.6) 12 (5.4)
Histologic type
  Conventional
    Nonkeratinizing 128 (60.4) 6 (50.0) 0.25*
    Nonkeratinizing with maturation 51 (24.1) 3 (25.0) 0.77*
    Keratinizing 7 (3.3) 2 (16.7) 0.036*
Subtypes
  Adenosquamous (Including Ciliated) 6 (2.8) 0 0.90**
  Lymphoepithelial 7 (3.3) 0
  Basaloid 3 (1.4) 0
  Papillary 11 (5.2) 1 (8.3)
Anaplasia present? 50 (23.6) 3 (25.0) 0.77
Multinucleation present? 83 (39.2) 4 (33.3) 0.73
Anaplasia and/or Multinucleation present? 99 (46.7) 6 (50.0) 0.45
Multinucleation Index (MNI) (Average)
  MNI 1 or more 117 (55.2) 6 (50.0) 0.51
  MNI 3 or more 88 (41.5) 5 (41.7) 0.39
  MNI 11 or more 31 (14.6) 3 (25.0) 0.39
Stromal desmoplasia (%) (Average)
  1% or more 129 (60.8) 7 (58.3) 0.61
  11% or more 51 (24.1) 2 (16.7) 0.20
  31% or more 10 (4.7) 2 (16.7) 0.11
Maturing squamous differentiation (%) (Average)
  1% or more 157 (74.1) 8 (66.7) 0.22
  11% or more 62 (29.2) 5 (41.7) 0.30
  31% or more 33 (15.6) 3 (25.0) 0.43
  51% or more 20 (9.4) 3 (25.0) 0.10

*Value for nonkeratinizing vs nonkeratinizing with maturation vs keratinizing

**Value for all variants combined vs all conventional SCC types